Signature »

Marinus Pharmaceuticals shares owned by Signature

Quarter-by-quarter ownership of Marinus Pharmaceuticals (MRNS) shares owned by Signature from 13F filings

Historical chart of Signature investment in Marinus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Marinus Pharmaceuticals held by Signature consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marinus Pharmaceuticals by Signature

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.7k 342 10.87
2023-09-30 $1.5k 187 8.05

More positions owned by Signature

Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Blackrock Ultra (ICSH)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr National Mun Etf (MUB)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Signature

Top funds holding Marinus Pharmaceuticals

Eventide Asset Management
Franklin Resources
Cormorant Asset Management
venBio Select Advisor
Jennison Associates
Vanguard Group
Lion Point Capital
Bleichroeder
GMT Capital Corp
Ikarian Capital
Citadel Advisors
Opaleye Management
Standard Life Aberdeen
Point72 Asset Management
Superstring Capital Management

View all funds holding Marinus Pharmaceuticals